Since Ozempic (semaglutide) came out of the gate after the U.S. Food and Drug Administration’s approval in 2017, it has become a blockbuster medication for treating type 2 diabetes.
Arriving on the market about four years later, the diabetes medication Mounjaro (tirzepatide) — which is in…
